Key points are not available for this paper at this time.
CDK8/19 inhibitors can convert naïve and memory/effector T cells into T reg cells capable of treating immunological diseases.
Share your take
Add a clinician perspective alongside expert commentary.
Akamatsu et al. (Fri,) studied this question.